GLVCX
Price
$74.59
Change
+$0.47 (+0.63%)
Updated
Jun 2 closing price
Net Assets
591.68M
NPFCX
Price
$69.71
Change
-$0.41 (-0.58%)
Updated
Jun 3 closing price
Net Assets
164.3B
Interact to see
Advertisement

GLVCX vs NPFCX

Header iconGLVCX vs NPFCX Comparison
Open Charts GLVCX vs NPFCXBanner chart's image
GLVCX vs NPFCX Comparison Chart in %
View a ticker or compare two or three
VS
GLVCX vs. NPFCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLVCX is a Hold and NPFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 164B vs. GLVCX (592M). NPFCX pays higher dividends than GLVCX: NPFCX (0.33) vs GLVCX (0.00). GLVCX was incepted earlier than NPFCX: GLVCX (19 years) vs NPFCX (25 years). GLVCX (1.98) is less costly to investors than NPFCX (1.47). NPFCX is a more actively managed with annual turnover of: 23.00 vs. GLVCX (17.00). NPFCX has a lower initial minimum investment than GLVCX: NPFCX (250) vs GLVCX (1000). NPFCX annual gain was more profitable for investors over the last year : 12.77 vs. GLVCX (4.35). NPFCX return over 5 years is better than : 13.27 vs. GLVCX (4.53).
GLVCXNPFCXGLVCX / NPFCX
Total Expense Ratio1.981.47135%
Annual Report Gross Expense Ratio1.981.47135%
Fund Existence19 years25 years-
Gain YTD11.2087.037159%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets592M164B0%
Annual Yield % from dividends0.000.33-
Returns for 1 year4.3512.7734%
Returns for 3 years38.4940.0496%
Returns for 5 years4.5313.2734%
Returns for 10 years94.59103.0692%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABEO5.700.07
+1.15%
Abeona Therapeutics
LZB36.43-0.71
-1.91%
La-Z-Boy
GE317.72-6.88
-2.12%
GE Aerospace
ALKS41.33-0.94
-2.22%
Alkermes plc
IXHL3.05-0.20
-6.15%
Incannex Healthcare Inc.